Novartis AG Total Liabilities
Novartis AG (NVSEF) had Total Liabilities of $64.40 billion as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:Liabilities · last filed 2026-02-04
- 2025-12-31: Liabilities $64.40B.
- 2025-06-30: Liabilities $62.34B.
- 2024-12-31: Liabilities $58.12B.
- 2024-06-30: Liabilities $55.60B.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2025-12-31 | $64.40B 20-F · filed 2026-02-04 | |
| 2025-06-30 | $62.34B 6-K · filed 2025-07-17 | |
| 2024-12-31 | $58.12B 20-F · filed 2026-02-04 | |
| 2024-06-30 | $55.60B 6-K · filed 2024-07-18 | |
| 2023-12-31 | $53.20B 20-F · filed 2025-01-31 | |
| 2023-06-30 | $59.05B 6-K · filed 2023-07-18 | |
| 2022-12-31 | $58.03B 20-F · filed 2024-01-31 | |
| 2022-06-30 | $59.90B 6-K · filed 2022-07-19 | |
| 2021-12-31 | $63.97B 20-F/A · filed 2023-05-15 | |
| 2021-06-30 | $69.89B 6-K · filed 2021-07-21 | |
| 2020-12-31 | $71.11B 20-F · filed 2022-02-02 | $75.39B 20-F · filed 2021-01-26 |
| 2020-06-30 | $69.88B 6-K · filed 2020-07-21 | |
| 2019-12-31 | $62.82B 20-F · filed 2021-01-26 | |
| 2019-06-30 | $64.79B 6-K · filed 2019-07-18 | |
| 2018-12-31 | $66.87B 20-F · filed 2020-01-29 | |
| 2018-06-30 | $65.16B 6-K · filed 2018-07-18 | |
| 2017-12-31 | $58.85B 20-F · filed 2019-01-30 | |
| 2016-12-31 | $55.23B 6-K · filed 2018-01-24 |